Form 4 for RXST RxSight, Inc.
Accepted 2023-12-29 00:00:00 ET · period of report 2023-12-27 · accession 0001209191-23-060012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-12-29 | 2023-12-27 | RXST | Kurtz Ronald M MD | Pres, CEO, Dir | S - Sale | $41.09 | -22.5K | 867.1K | -3% | -$924.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-27 | S | D | 22,500 | $41.09 | 867,110 | I See footnote | — | — | (F2) Represents the weighted average share price of an aggregate total of 22,500 shares sold in the price range of $41.00 to $41.2875 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse. |